Fierce JPM Week 2025

The global Pharmacovigilance (PV)/Drug Safety market, valued at $8.5 billion in 2024, is projected to grow to $19.1 billion by 2034, reflecting the increasing importance of safety monitoring in life sciences R&D.  To support this growing trend, recent years have seen the emergence of innovative disruptors, reshaping traditional industry practices with new approaches and technologies.  A major trend in the industry has been the integration of advanced, AI-driven solutions that streamline and enhance PV operations.

In this session, Raj More, Chief Architect & CEO of RxLogix Corporation will discuss how a fully integrated AI-drive digital platform has the potential to expand into Clinical and Regulatory Information Management systems, paving the way for a holistic end-to-end Life Sciences platform. Mr. More will also highlight specific examples of how the RxLogix Safety Platform (RSP) drives substantial positive impacts for both life sciences companies and regulatory Agencies by increasing efficiency and allowing for consolidation and cost savings.